Low‐intervention clinical trials in Spain: Do they progress?
Despite their critical role in establishing effectiveness and safety of authorized medicinal products in pragmatic clinical settings, LICTs still constitute a relatively small proportion of all clinical trials approved in Spain, and their designs have area for improvement in terms of robustness. There was no apparent effect of CTIS implementation on LICTs activity.
Authors
- Caridad Pontes (ORCID: https://orcid.org/0000-0002-3274-6048)
- Kristopher Amaro-Hosey (ORCID: https://orcid.org/0000-0003-3801-1568)
- M. Pestana (ORCID: https://orcid.org/0009-0009-8311-7506)
- Rosa Antonijoan Arbós (ORCID: https://orcid.org/0000-0002-7099-5125)
- Claudia Erika Delgado‐Espinoza (ORCID: https://orcid.org/0009-0009-9089-4784)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1002/bcp.70409
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00